Inventor · disambiguated record
Mark B. Roth
Also filed as: ROTH MARK · ROTH MARK B
5 granted patents·25 pending applications·56 citations·filing 1999–2025
78Inventor score
Files withHUTCHINSON FRED CANCER RES13ROTH MARK B10FARADAY PHARMACEUTICALS INC3FRED HULCHINSON CANCER RES CT1FRED HUTCHINSON CANCER CENTER1
Top patents by PatentIndex Score
30 records- 0177US6596501B2Method of diagnosing autoimmune diseaseHUTCHINSON FRED CANCER RES·Filed 1999·Granted Jul 22, 2003·47 cites·16 claims
- 0276US10201570B2Halogen treatment of heart attack and ischemic injuryHUTCHINSON FRED CANCER RES·Filed 2015·Granted Feb 12, 2019·2 cites·8 claims
- 0374US12016880B2Halogen treatment of heart attack and ischemic injuryFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Jun 25, 2024·0 cites·22 claims
- 0471US7993681B2Methods, compositions and devices for inducing stasis in tissues and organsHUTCHINSON FRED CANCER RES·Filed 2004·Granted Aug 9, 2011·5 cites·27 claims
- 0567US2025367232A1Halogen treatment of heart attack and ischemic injuryHUTCHINSON FRED CANCER RES·Filed 2025·Application pending·0 cites
- 0666US8822535B2Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organismsROTH MARK B·Filed 2006·Granted Sep 2, 2014·2 cites·3 claims
- 0765US2015164064A1Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organismsHUTCHINSON FRED CANCER RES·Filed 2014·Application pending·0 cites
- 0860US2008171093A1Methods, Compositions and Devices for Inducing Stasis in Cells, Tissues, Organs, and OrganismsHUTCHINSON FRED CANCER RES·Filed 2007·Application pending·0 cites
- 0960US2008085329A1Methods, Compositions and Devices for Inducing Stasis in Cells, Tissues, Organs, and OrganismsHUTCHINSON FRED CANCER RES·Filed 2007·Application pending·0 cites
- 1057US2010021387A1Methods for Inducing Reversible StasisHUTCHINSON FRED CANCER RES·Filed 2009·Application pending·0 cites
- 1157US2020016194A1Halogen treatment of heart attack and ischemic injuryHUTCHINSON FRED CANCER RES·Filed 2018·Application pending·0 cites
- 1256US2008318864A1Methods and compositions regarding polychalcogenide compositionsHUTCHINSON FRED CANCER RES·Filed 2008·Application pending·0 cites
- 1353US2005170019A1Methods, compositions and devices for inducing stasis in cellsHUTCHINSON FRED CANCER RES·Filed 2004·Application pending·0 cites
- 1449US2008171726A1Methods, Compositions and Articles of Manufacture for Enhancing Survivability of Cells, Tissues, Organs, and OrganismsROTH MARK B·Filed 2007·Application pending·0 cites
- 1549US2008171725A1Methods, Compositions and Articles of Manufacture for Enhancing Survivability of Cells, Tissues, Organs, and OrganismsROTH MARK B·Filed 2007·Application pending·0 cites
- 1648US2012244067A1Methods for inducing reversible stasisROTH MARK B·Filed 2012·Application pending·0 cites
- 1748US2022387483A1Use of iodide compounds for the treatment and prevention of chemotherapy-associated cachexia and cardiotoxicityFARADAY PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1848US2016361356A1Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organismsHUTCHINSON FRED CANCER RES·Filed 2016·Application pending·0 cites
- 1947US2005136125A1Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organismsFiled 2004·Application pending·0 cites
- 2047US2009011051A1Methods, Compositions and Articles of Manufacture for HIF Modulating CompoundsROTH MARK B·Filed 2007·Application pending·0 cites
- 2147US2012052479A1Methods, compositions and devices for inducing stasis in tissues and organsROTH MARK B·Filed 2011·Application pending·0 cites
- 2246US2005053912A1Methods for inducing reversible stasisFiled 2002·Application pending·0 cites
- 2345US2008226750A1Methods, Compositions and Articles of Manufacture for Treating Shock and Other Adverse ConditionsHUTCHINSON FRED CANCER RES·Filed 2007·Application pending·0 cites
- 2445US2012135091A1Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenidesROTH MARK B·Filed 2008·Application pending·0 cites
- 2543US2012040024A1Methods and compositions for enhancing survivability of cells, tissues, organs and organismsROTH MARK B·Filed 2011·Application pending·0 cites
- 2642US2013252897A1Methods and Compositions Regarding Polychalcogenide CompositionsROTH MARK B·Filed 2012·Application pending·0 cites
- 2741US2021252047A1Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndromeFARADAY PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2841US2020096496A1Iodide detection in blood plasma samplesFARADAY PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2939US2012282353A1Methods, compositions and articles of manufacture for hif modulating compoundsROTH MARK B·Filed 2012·Application pending·0 cites
- 3037US2015290240A1Compositions comprising chalcogenides and related mattersFRED HULCHINSON CANCER RES CT·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark B. Roth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →